ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
15 hedge funds and large institutions have $1.94M invested in Acorda Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Holders
15
Holding in Top 10
–
Calls
$347K
Puts
$91K
Top Buyers
| 1 | +$16.9K | |
| 2 | +$10.4K | |
| 3 | +$6.78K | |
| 4 |
BlackRock
New York
|
+$39 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$26 |
Top Sellers
| 1 | -$455K | |
| 2 | -$128K | |
| 3 | -$102K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$93.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$82.7K |